Inventor
WALL MARK J
US21 patents
⚠️ This page may combine multiple inventors who share the name “WALL MARK J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
18 patentsUS7795279B2Sep 14, 2010
Method of inhibiting FLT3 kinase
JANSSEN PHARMACEUTICA NV30 citations92
US7662837B2Feb 16, 2010
Inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV26 citations91
US7645755B2Jan 12, 2010
Inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV45 citations91
US11767354B2Sep 26, 2023
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
JANSSEN PHARMACEUTICA NV3 citations83
US11591379B2Feb 28, 2023
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
JANSSEN PHARMACEUTICA NV3 citations83
US11401315B2Aug 2, 2022
Immunoglobulins and uses thereof
JANSSEN PHARMACEUTICA NV2 citations83
US10968265B2Apr 6, 2021
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
JANSSEN PHARMACEUTICA NV4 citations83
US10858413B2Dec 8, 2020
Immunoglobulins and uses thereof
JANSSEN PHARMACEUTICA NV3 citations83
US10787495B2Sep 29, 2020
Immunoglobulins and uses thereof
JANSSEN PHARMACEUTICA NV3 citations83
US10961293B2Mar 30, 2021
Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
JANSSEN PHARMACEUTICA NV2 citations73
US12134636B2Nov 5, 2024
Immunoglobulins and uses thereof
JANSSEN PHARMACEUTICA NV0 citations72
US7326788B2Feb 5, 2008
Quinolinone derivatives as inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV8 citations71
US11732019B2Aug 22, 2023
Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
JANSSEN PHARMACEUTICA NV0 citations62
US7705042B2Apr 27, 2010
Class of arylamide compounds useful as inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV3 citations60
US9526731B2Dec 27, 2016
Method of inhibiting C-KIT kinase
JANSSEN PHARMACEUTICA NV0 citations50
US8933091B2Jan 13, 2015
Method of inhibiting C-KIT kinase
JANSSEN PHARMACEUTICA NV0 citations50
US10875902B2Dec 29, 2020
Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
JANSSEN PHARMACEUTICA NV0 citations49
US10077241B2Sep 18, 2018
Tetrahydro-benzoimidazolyl modulators of TGR5
JANSSEN PHARMACEUTICA NV0 citations42